SCOPUS 정보 검색 플랫폼

Volumn 54, Issue , 2012, Pages 690-696

Synthesis and biological activity evaluation of cytidine-5′-deoxy-5- fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2′,3′-carbonates

(6) Jhansi Rani, V a,e Raghavendra, A b Kishore, P c Nanda Kumar, Y a Hema Kumar, K d Jagadeeswarareddy, K e

a SRI VENKATESWARA UNIVERSITY (India)

b THAPAR UNIVERSITY (India)

c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE (United States)

d SVS Medical College Campus (India)

e Sugen Life Sciences Pvt Ltd (India)

Author keywords

5 Deoxy 5 fluorocytidine; 5 Fluorouracil; Antitumor activity; Capecitabine; Toxicity

Indexed keywords

5' DEOXY 5 FLUORO N4 (2 METHYL 1 BUTYLOXYCARBONYL)CYTIDINE; 5' DEOXY 5 FLUORO N4 (2 METHYL 1 BUTYLOXYCARBONYL)CYTIDINE 2',3' CARBONIC ACID; 5' DEOXY 5 FLUORO N4 (3 METHYL 1 BUTYLOXYCARBONYL)CYTIDINE; 5' DEOXY 5 FLUORO N4 (3 METHYL 1 BUTYLOXYCARBONYL)CYTIDINE 2',3' CARBONIC ACID; 5' DEOXY 5 FLUORO N4 (4 CHLOROPHENYLOXYCARBONYL)CYTIDINE; 5' DEOXY 5 FLUORO N4 (4 CHLOROPHENYLOXYCARBONYL)CYTIDINE 2',3' CARBONIC ACID; 5' DEOXY 5 FLUORO N4 (4 NITROPHENYLOXYCARBONYL)CYTIDINE; 5' DEOXY 5 FLUORO N4 (4 NITROPHENYLOXYCARBONYL)CYTIDINE 2',3' CARBONIC ACID; 5' DEOXY 5 FLUORO N4 (N PENTYLOXYCARBONYL)CYTIDINE; 5' DEOXY 5 FLUORO N4 (N PENTYLOXYCARBONYL)CYTIDINE 2',3' CARBONIC ACID; 5' DEOXY 5 FLUOROCYTIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; NONHUMAN; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMISTRY TECHNIQUES, SYNTHETIC; DEOXYCYTIDINE; DRUG DESIGN; FLUOROURACIL; HUMANS; INHIBITORY CONCENTRATION 50; MICE; SALMONELLA TYPHIMURIUM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84864399291 PISSN: 02235234 EISSN: 17683254 Source Type: Journal
DOI: 10.1016/j.ejmech.2012.06.023 Document Type: Article

Times cited : (18)

References (20)

1
- 41349099104
- A. Jemel, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun CA Cancer J. Clin. 58 2008 71 96
- (2008) CA Cancer J. Clin. , vol.58 , pp. 71-96
- Jemel, A.¹ Siegel, R.² Ward, E.³ Murray, T.⁴ Xu, J.⁵ Thun, M.J.⁶

2
- 54149090275
- WHO WHO Geneva
- WHO The Global Burden of Disease, 2004 Update 2008 WHO Geneva
- (2008) The Global Burden of Disease, 2004 Update

3
- 0343337640
- A.K. Sinhababu, and D.R. Thakker Adv. Drug Deliver. 19 1996 241
- (1996) Adv. Drug Deliver. , vol.19 , pp. 241
- Sinhababu, A.K.¹ Thakker, D.R.²

4
- 2942648695
- T.A. Rich, R.C. Shepard, and S.T. Mosley J. Clin. Oncol. 22 2004 2214 2232
- (2004) J. Clin. Oncol. , vol.22 , pp. 2214-2232
- Rich, T.A.¹ Shepard, R.C.² Mosley, S.T.³

5
- 0030931682
- R.M. Bukowski Cancer 80 1997 1198
- (1997) Cancer , vol.80 , pp. 1198
- Bukowski, R.M.¹

6
- 0032820506
- A.A. Adjei Br. J. Clin. Pharmacol. 48 1999 265
- (1999) Br. J. Clin. Pharmacol. , vol.48 , pp. 265
- Adjei, A.A.¹

7
- 0043065360
- F. McDonald, and D. Miles Int. J. Clin. Pract. 57 2003 530
- (2003) Int. J. Clin. Pract. , vol.57 , pp. 530
- McDonald, F.¹ Miles, D.²

8
- 72049107467
- S. Chitra, D. Devanathan, and K. Pandiarajan Eur. J. Med. Chem. 45 2010 367 371
- (2010) Eur. J. Med. Chem. , vol.45 , pp. 367-371
- Chitra, S.¹ Devanathan, D.² Pandiarajan, K.³

9
- 0029894336
- A. Zatorski, A.K. Watanabe, F.S. Carr, M.B. Goldstein, and W.K. Pankiewicz J. Med. Chem 39 1996 2422 2426
- (1996) J. Med. Chem , vol.39 , pp. 2422-2426
- Zatorski, A.¹ Watanabe, A.K.² Carr, F.S.³ Goldstein, M.B.⁴ Pankiewicz, W.K.⁵

10
- 0033945216
- N. Shimma, I. Umeda, M. Arasaki, C. Murasaki, K. Masubuchi, Y. Kohchi, M. Miwa, M. Ura, N. Sawada, H. Tahara, I. Kuruma, I. Horri, and H. Ishitsuka Bioorg. Med. Chem. 8 2000 1697 1706
- (2000) Bioorg. Med. Chem. , vol.8 , pp. 1697-1706
- Shimma, N.¹ Umeda, I.² Arasaki, M.³ Murasaki, C.⁴ Masubuchi, K.⁵ Kohchi, Y.⁶ Miwa, M.⁷ Ura, M.⁸ Sawada, N.⁹ Tahara, H.¹⁰ Kuruma, I.¹¹ Horri, I.¹² Ishitsuka, H.¹³

11
- 0006366727
- R.I. Geran, N.H. Greenberg, M.M. Macdonald, A.M. Schumacher, and B.J. Abbott Cancer Chemother. Rep, Part, 3 1972 3
- (1972) Cancer Chemother. Rep, Part, 3 , pp. 3
- Geran, R.I.¹ Greenberg, N.H.² MacDonald, M.M.³ Schumacher, A.M.⁴ Abbott, B.J.⁵

12
- 80051585753
- adopted December 17
- OECD Guidelines for testing of chemicals "acute oral toxicity", No. 423: adopted December 17, 2001.
- (2001) OECD Guidelines for Testing of Chemicals "acute Oral Toxicity, No. 423

13
- 0012997805
- Bacterial Reverse Mutation Test", adopted July 21
- OECD Guidelines for testing of chemicals, No. 471: "Bacterial Reverse Mutation Test", adopted July 21, 1997.
- (1997) OECD Guidelines for Testing of Chemicals, No. 471

14
- 0004255158
- third ed. Thieme Stuttgart, New York
- A. Kleemann, J. Engel, B. Kutscher, and D. Reichert Pharmaceutical Substances third ed. 1999 Thieme Stuttgart, New York p. 840
- (1999) Pharmaceutical Substances , pp. 840
- Kleemann, A.¹ Engel, J.² Kutscher, B.³ Reichert, D.⁴

15
- 0344554831
- Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test
- B.J. Kilbey, Elsevier Amsterdam
- B.N. Ames, J. McCann, and E. Yamasaki Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test B.J. Kilbey, Handbook of Mutagenicity Test Procedures 1977 Elsevier Amsterdam 1 17
- (1977) Handbook of Mutagenicity Test Procedures , pp. 1-17
- Ames, B.N.¹ McCann, J.² Yamasaki, E.³

16
- 0018367882
- Recommendations on data production and analysis using the Salmonella/microsome mutagenicity assay
- F.J. De Serres, and M.D. Shelby Recommendations on data production and analysis using the Salmonella/microsome mutagenicity assay Mutat. Res. 64 1979 159 165 (Pubitemid 9199038)
- (1979) Mutation Research , vol.64 , Issue.3 , pp. 159-165
- De Serres, F.J.¹ Shelby, M.D.²

17
- 84864404462
- USEPA Prevention, Pesticides and Toxic Substances (7101) United States Environmental Protection Agency
- USEPA Part 712-C-98-247, Health Effects Test Guidelines OPPTS 870.5100, Bacterial Reverse Mutation Test Prevention, Pesticides and Toxic Substances (7101) August 1998 United States Environmental Protection Agency
- (1998) Part 712-C-98-247, Health Effects Test Guidelines OPPTS 870.5100, Bacterial Reverse Mutation Test

18
- 0020533372
- Revised methods for the Salmonella mutagenicity test
- D.M. Maron, and B.N. Ames Revised methods for the Salmonella mutagenicity test Mutat. Res. 113 1983 173 215 (Pubitemid 13120319)
- (1983) Mutation Research , vol.113 , Issue.3-4 , pp. 173-215
- Maron, D.M.¹ Ames, B.N.²

19
- 43049121003
- I. ilović, M. Rubčić, V. Vrdoljak, S. Kraljević Pavelić, M. Kralj, I. Piantanida, and M. Cindrić Bioorg. Med. Chem. 16 2008 5189 5198
- (2008) Bioorg. Med. Chem. , vol.16 , pp. 5189-5198
- Ilović, I.¹ Rubčić, M.² Vrdoljak, V.³ Kraljević Pavelić, S.⁴ Kralj, M.⁵ Piantanida, I.⁶ Cindrić, M.⁷

20
- 84864400486
- Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910 Montreal, QC, Canada, H3A 2R7
- Molecular Operating Environment (MOE), 2011.10 2011 Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910 Montreal, QC, Canada, H3A 2R7
- (2011) Molecular Operating Environment (MOE), 2011.10

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.